Estimated Impact of Achieving Optimal Cardiovascular Health Among US Adults on Cardiovascular Disease Events

被引:37
|
作者
Bundy, Joshua D. [1 ,2 ]
Zhu, Zhengbao [1 ]
Ning, Hongyan [3 ]
Zhong, Victor W. [4 ]
Paluch, Amanda E. [5 ]
Wilkins, John T. [3 ,6 ]
Lloyd-Jones, Donald M. [3 ,6 ]
Whelton, Paul K. [1 ,2 ,7 ]
He, Jiang [1 ,2 ,7 ]
Allen, Norrina B. [3 ]
机构
[1] Tulane Univ, Sch Publ Hlth & Trop Med, Dept Epidemiol, 1440 Canal St,Suite 2000, New Orleans, LA 70112 USA
[2] Tulane Univ, Translat Sci Inst, New Orleans, LA 70112 USA
[3] Northwestern Univ, Feinberg Sch Med, Dept Prevent Med, Chicago, IL 60611 USA
[4] Shanghai Jiao Tong Univ, Sch Med, Sch Publ Hlth, Dept Epidemiol & Biostat, Shanghai, Peoples R China
[5] Univ Massachusetts, Dept Kinesiol, Amherst, MA 01003 USA
[6] Northwestern Univ Feinberg, Sch Med, Dept Med, Div Cardiol, Chicago, IL USA
[7] Tulane Univ, Sch Med, Dept Med, 1430 Tulane Ave, New Orleans, LA 70112 USA
来源
JOURNAL OF THE AMERICAN HEART ASSOCIATION | 2021年 / 10卷 / 07期
基金
美国国家卫生研究院;
关键词
cardiovascular disease; epidemiology; health status disparities; prevention; risk factors; ARTERY RISK DEVELOPMENT; LIFE-STYLE; MORTALITY; HEART; ASSOCIATIONS; PROMOTION; COMMUNITY; ATHEROSCLEROSIS; PREVENTION; OUTCOMES;
D O I
10.1161/JAHA.120.019681
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background Better cardiovascular health (CVH) scores are associated with lower risk of cardiovascular disease (CVD). However, estimates of the potential population-level impact of improving CVH on US CVD event rates are not currently available. Methods and Results Using data from the National Health and Nutrition Examination Survey 2011 to 2016 (n=11 696), we estimated the proportions of US adults in CVH groups. Levels of 7 American Heart Association CVH metrics were scored as ideal (2 points), intermediate (1 point), or poor (0 points), and summed to define overall CVH (low, 0-8 points; moderate, 9-11 points; or high, 12-14 points). Using individual-level data from 7 US community-based cohort studies (n=30 447), we estimated annual incidence rates of major CVD events by levels of CVH. Using the combined data sources, we estimated population attributable fractions of CVD and the number of CVD events that could be prevented annually if all US adults achieved high CVH. High CVH was identified in 7.3% (95% CI, 6.3%-8.3%) of US adults. We estimated that 70.0% (95% CI, 56.5%-79.9%) of CVD events were attributable to low and moderate CVH. If all US adults attained high CVH, we estimated that 2.0 (95% CI, 1.6-2.3) million CVD events could be prevented annually. If all US adults with low CVH attained moderate CVH, we estimated that 1.2 (95% CI, 1.0-1.4) million CVD events could be prevented annually. Conclusions The potential benefits of achieving high CVH in all US adults are considerable, and even a partial improvement in CVH scores would be highly beneficial.
引用
收藏
页数:26
相关论文
共 50 条
  • [21] Modest Gains Confer Large Impact: Achievement of Optimal Cardiovascular Health in the US Population
    Michos, Erin D.
    Khan, Sadiya S.
    JOURNAL OF THE AMERICAN HEART ASSOCIATION, 2021, 10 (07):
  • [22] The impact of cardiovascular health on mortality in US adults with cardiometabolic disease: A prospective nationwide cohort study
    Zhang, Feifei
    Liu, Huiliang
    Xie, Yuetao
    Liu, Litian
    Feng, Ohua
    Li, Yingxiao
    NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES, 2025, 35 (02)
  • [23] Health characteristics and predicted 10-year risk for a first atherosclerotic cardiovascular disease (ASCVD) event using the Pooled Cohort Risk Equations among US adults who are free of cardiovascular disease
    Loprinzi, Paul D.
    Nooe, Allison
    PHYSIOLOGY & BEHAVIOR, 2015, 151 : 591 - 595
  • [24] Five-Year Cumulative Cardiovascular Health and Clinical Events in Patients With Chronic Kidney Disease: The CRIC Study
    Cao, Qiuyu
    Bi, Yufang
    Alvarado, Flor
    Anderson, Amanda H.
    Mills, Katherine T.
    Jaeger, Byron C.
    Chen, Jing
    He, Jiang
    Bundy, Joshua D.
    JOURNAL OF THE AMERICAN HEART ASSOCIATION, 2024, 13 (10):
  • [25] Achieving Optimal Cardiovascular Health: a Social Epidemiological Approach
    de Baca, Tomas Cabeza
    Durazo, Eva M.
    Rodriguez, Fatima
    CURRENT EPIDEMIOLOGY REPORTS, 2018, 5 (03) : 262 - 271
  • [26] Relationship Between Control of Cardiovascular Risk Factors and Chronic Kidney Disease Progression, Cardiovascular Disease Events, and Mortality in Chinese Adults
    Geng, Tingting
    Xu, Wenqi
    Gao, Huanqing
    Zhang, Jijuan
    Zou, Jiaojiao
    Wang, Kaiyue
    Li, Junjuan
    Guo, Lu
    Wang, Guodong
    Chen, Shuohua
    Huang, Tao
    Pan, An
    Gao, Xiang
    Wu, Shouling
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2024, 84 (14) : 1313 - 1324
  • [27] Impact of changing reimbursement criteria on statin treatment patterns among patients with atherosclerotic cardiovascular disease or cardiovascular risk factors
    Hsu, Chia-Yun
    Chen, Wen-Jone
    Chen, Ho-Ming
    Tsai, Hsin-Yi
    Hsiao, Fei-Yuan
    JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS, 2021, 46 (02) : 415 - 423
  • [28] Impaired Renal Function and Major Cardiovascular Events in Young Adults
    Hussain, Junayd
    Imsirovic, Haris
    Canney, Mark
    Clark, Edward G.
    Elliott, Meghan J.
    Ravani, Pietro
    Tanuseputro, Peter
    Akbari, Ayub
    Hundemer, Gregory L.
    Ramsay, Tim
    Tangri, Navdeep
    Knoll, Greg A.
    Sood, Manish M.
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2023, 82 (13) : 1316 - 1327
  • [29] Impact of cardiovascular health and genetic risk on coronary artery disease in Chinese adults
    Cui, Qingmei
    Liu, Zhongying
    Li, Jianxin
    Liu, Fangchao
    Niu, Xiaoge
    Shen, Chong
    Hu, Dongsheng
    Huang, Keyong
    Chen, Shufeng
    Zhao, Yingxin
    Lu, Fanghong
    Liu, Xiaoqing
    Cao, Jie
    Wang, Laiyuan
    Ma, Hongxia
    Yu, Ling
    Wu, Xianping
    Li, Ying
    Zhang, Huan
    Mo, Xingbo
    Zhao, Liancheng
    Hu, Zhibin
    Shen, Hongbing
    Huang, Jianfeng
    Lu, Xiangfeng
    Gu, Dongfeng
    HEART, 2023, 109 (10) : 756 - 762
  • [30] Cost Estimation of Cardiovascular Disease Events in the US
    O'Sullivan, Amy K.
    Rubin, Jaime
    Nyambose, Joshua
    Kuznik, Andreas
    Cohen, David J.
    Thompson, David
    PHARMACOECONOMICS, 2011, 29 (08) : 693 - 704